These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 115935)

  • 21. [Massive cefmetazole (CS-1170) therapy for extremely severe respiratory infections (author's transl)].
    Isawa T; Teshima T; Hirano T; Ebina A; Konno K
    Jpn J Antibiot; 1980 Aug; 33(8):758-66. PubMed ID: 6937692
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical evaluation of 6059-S in children, particularly in the treatment of bacterial meningitis (author's transl)].
    Kobayashi Y; Haruta T; Kuroki S; Okura K; Fujiwara T; Morikawa Y
    Jpn J Antibiot; 1981 Apr; 34(4):587-98. PubMed ID: 6457167
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clinical study on 6059-S in children (author's transl)].
    Yanagisawa K; Ide K; Hoshina H; Ichihashi H
    Jpn J Antibiot; 1981 May; 34(5):757-63. PubMed ID: 6457174
    [No Abstract]   [Full Text] [Related]  

  • 24. [Studies on cefmetazole (author's transl)].
    Seiga K; Minakawa M; Ekawa J; Yamaji K; Sugiyama Y
    Jpn J Antibiot; 1979 Apr; 32(4):525-31. PubMed ID: 459082
    [No Abstract]   [Full Text] [Related]  

  • 25. [Clinical experience of therapeutic use of cefmetazole (cefmetazon) or bronchopneumonia (author's transl)].
    Murao M; Terai T; Kirisawa T; Kon H; Moriyama Y; Hattori T
    Jpn J Antibiot; 1981 Jun; 34(6):856-63. PubMed ID: 6945446
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Bacteriological and clinical studies of 6059-S in pediatric infections (author's transl)].
    Terashima I; Nakamura A; Okimoto U; Sugaya N; Kurosaki T; Sato T; Iwata Y; Saito N; Uehara S
    Jpn J Antibiot; 1981 May; 34(5):747-56. PubMed ID: 6457173
    [No Abstract]   [Full Text] [Related]  

  • 27. [Review [new antibiotics series IV]: latamoxef (author's transl)].
    Matsumoto K
    Jpn J Antibiot; 1982 Mar; 35(3):704-13. PubMed ID: 6212703
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinical usefulness of cefmetazole in newborn and immature infants (author's transl)].
    Jpn J Antibiot; 1981 Jun; 34(6):893-902. PubMed ID: 6945449
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical study of CS-1170 in children (author's transl)].
    Nagamatsu K; Hamada I
    Jpn J Antibiot; 1979 Feb; 32(2):238-40. PubMed ID: 439395
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A study of safety of cefmetazole (CS-1170) in pregnant women during the perinatal stage (author's transl)].
    Jpn J Antibiot; 1981 Jun; 34(6):907-14. PubMed ID: 6945451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cefmetazole in the treatment of bacterial infections in the newborn (author's transl)].
    Kobayashi Y; Haruta T; Morikawa Y; Kuroki S; Okura K; Fujiwara T
    Jpn J Antibiot; 1980 Nov; 33(11):1237-46. PubMed ID: 6941035
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical experience with CS-1170 in children (author's transl)].
    Hori M; Kouno S; Hashimoto F; Kurosu Y; Toyonaga Y
    Jpn J Antibiot; 1979 Jan; 32(1):29-34. PubMed ID: 423364
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of cefmetazole and piperacillin with or without tobramycin for infections in patients with hematological disorders.
    Nagao T; Komatsuda M; Yamauchi K; Nozaki H; Arimori S
    Tokai J Exp Clin Med; 1981 Oct; 6(4):415-20. PubMed ID: 6459664
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical effect of CS-1170 (author's transl)].
    Oshima K; Ueda N; Hayata S; Tei N; Usugane M; Nakano Y
    Jpn J Antibiot; 1979 Mar; 32(3):339-41. PubMed ID: 439403
    [No Abstract]   [Full Text] [Related]  

  • 35. [Evaluation of the effect of a cephamycin antibiotic agent, cefmetazole, for the postoperative infections (author's transl)].
    Jpn J Antibiot; 1981 Sep; 34(9):1211-34. PubMed ID: 6948969
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pharmacokinetics and clinical studies of cefmetazole in the otorhinolaryngological field].
    Wada K; Baba S; Hatano T; Murai K; Kinoshita H; Takimoto I; Nomura T; Naito M; Iwata S; Nishimura T; Takasu A; Sekiya T; Miyagawa K; Tsukiyama M; Ito H; Suzuki Y; Hondoh J; Noda M; Umeda K; Maruo T
    Jpn J Antibiot; 1982 May; 35(5):1261-90. PubMed ID: 6752461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Basic and clinical examinations of CS-1170 in pediatrics (author's transl)].
    Nanri S; Sunakawa K; Hara N; Yamashita N; Akita H; Hotta M; Izeki M; Morikawa Y; Osano M; Ichihashi Y
    Jpn J Antibiot; 1979 Jan; 32(1):18-24. PubMed ID: 370423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Experience with cefmetazole in the urological fields].
    Tajima A; Ohmi Y; Masuda H; Ushiyama T; Fujii K; Hata M; Ohta N; Suzuki K; Fujita K; Aso Y
    Jpn J Antibiot; 1982 Aug; 35(8):1961-6. PubMed ID: 6961241
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cefmetazole preparations].
    Jpn J Antibiot; 1981 Jun; 34(6):925-8. PubMed ID: 6945453
    [No Abstract]   [Full Text] [Related]  

  • 40. [Fundamental and clinical evaluations of cefmetazole against dermal infections by S. aureus (author's transl)].
    Watanabe Y; Yokoyama M; Itoh K; Yamada K
    Jpn J Antibiot; 1982 Jan; 35(1):261-7. PubMed ID: 6951062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.